Cardiovascular
Articles
Taking action to address Europe’s non-communicable disease epidemic
Stefan Woxström at AstraZeneca considers the high rates of non-communicable diseases and how governments and healthcare systems can improve their treatments
1 October 2023Cardiovascular
Pandemics and lessons learnt: COVID-19 and CVD
Pharmafile speaks to Scott Curley about CVD, the impact COVID-19 had on the pharma industry specifically in relation to CVD and the next steps for cardiovascular treatment in the UK
1 October 2023Cardiovascular
Diuretic-resistant congestion– The road less travelled in novel treatments for chronic heart failure
What treatments can be used for diuretic-resistant congestion in chronic heart failure, and what challenges face them?
1 December 2022Cardiovascular
How RNA-based therapeutics improve care and benefit patients
Patients can benefit from new RNA-based therapeutics for metabolic care
1 December 2022Cardiovascular
Addressing inequalities in access to medicines in a post-COVID world
The challenge of cardiovascular disease: Daiichi Sankyo tells Pharmafile about their role in improving access to cardiovascular treatments and the prevention of CVD
1 December 2022Cardiovascular
Pharmafile
Therapeutic areas in focus